Potential Application of Benzo(a)Pyrene-Associated Adducts (Globin or Lipid) as Blood Biomarkers for Target Organ Exposure and Human Risk Assessment

REFERENCES

• Anderson, M. W., and Bend, J. R. 1983. In vivo metabolism of benzo(a)pyrene: Formation and disappearance of BP-metabolite–DNA adducts in extrahepatic tissues versus liver. In Extrahepatic drug metabolism and chemical carcinogenesis: Proceedings of the International Meeting on Extrahepatic Drug Metabolism and Chemical Carcinogenesis, Stockholm, Sweden, May 17–20, 459–467. New York, NY: Elsevier Science.
   Google Scholar
• Aylward, L. L., Hays, S. M., Smolders, R., Koch, H. M., Cocker, J., Jones, K., Warren, N., Levy, L., and Bevan, R. 2014. Sources of variability in biomarker concentrations. J. Toxicol. Environ. Health B 17: 45–61.
   PubMed Web of Science ®Google Scholar
• Bartsch, H., Arab, K., and Nair, J. 2011. Biomarkers for hazard identification in humans. Environ. Health 10( suppl, 1): S11.
   PubMed Web of Science ®Google Scholar
• Beland, F. A., and Poirier, M. C. 1989. DNA adduct nd carcinogenesis. In The pathobiology of neoplasia, ed. A. E. Sirica, 57–80. New York, NY: Plenum Press.
   Google Scholar
• Beland, F. A., and Poirier, M. C. 1993. Significance of DNA adduct studies in animal models for cancer molecular dosimetry and risk assessment. Environ. Health Perspect. 99: 5–10.
   PubMed Web of Science ®Google Scholar
• Beyerbach, A., Rothman, N., Bhatnagar, V. K., Kashyap, R., and Sabbioni, G. 2006. Hemoglobin adducts in workers exposed to benzidine and azo dyes. Carcinogenesis 27: 1600–1606.
   PubMed Web of Science ®Google Scholar
• Brookes, P., and Lawley, P. 1964. Evidence of the binding of polycyclic aromatic hydrocarbons to nucleic acids of the mouse skin: Relationship between carcinogenic power of hydrocarbons and their binding to DNA. Nature 202: 781–784.
   PubMed Web of Science ®Google Scholar
• Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem. 72: 248–254.
   PubMed Web of Science ®Google Scholar
• Calleman, C. J., Ehrenberg, L., Jansson, B., Osterman-Golker, S., Segerback, D., Svensson, K., and Wachtneister, C.A. 1978. Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide. J. Environ. Pathol. Toxicol. 2: 427–442.
   PubMed Web of Science ®Google Scholar
• Calleman, C. J. 1982. In vivo dosimetry by means of alkylated hemoglobin—A tool in the design of tests for genotoxic effects. In Banbury Report: Indicators of genotoxic exposure, ed. B. A. Bridges, B. E. Butterworth, and I. B. Weinstein, 157–167. New York, NY: CSH Lab.
   Google Scholar
• Choi, M. J., Lee, J. W., and B. M. 1996. Comparative assessment of DNA adduct formation, Salmonella mutagenicity, and chromosome aberration assays as short-term tests for DNA damage. J. Toxicol. Environ. Health 49: 271–284.
   PubMed Web of Science ®Google Scholar
• DeCaprio, A. P. 1997. Biomarkers: Coming of age for environmental health and risk assessment. Environ. Sci. Technol. 31: 1837–1848.
   Web of Science ®Google Scholar
• DeMarini, D. M. 2013. Genotoxicity biomarkers associated with exposure to traffic and near-road atmospheres: A review. Mutagenesis 28: 485–505.
   PubMed Web of Science ®Google Scholar
• Dunn, B. P. 1983. Wide-range linear dose-response curve for DNA binding of orally administered benzo(a)pyrene in mice. Cancer Res. 43: 2654–2658.
   PubMed Web of Science ®Google Scholar
• Dunn, B. P. 1991. Carcinogen adducts as an indicator for the public health risks of consuming carcinogen-exposed fish and shellfish. Environ. Health Perspect. 90: 111–116.
   PubMed Web of Science ®Google Scholar
• Eastman, A., Sweetenham, J., and Bresnick, E. 1978. Comparison of in vivo and in vitro binding of polycyclic hydrocarbons to DNA. Chem. Biol. Interact. 23: 345–353.
   PubMed Web of Science ®Google Scholar
• Folch, J., Lees, M., and Stanley, G. H. S. 1957. A simple methods for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497–509.
   PubMed Web of Science ®Google Scholar
• Gorlewska-Roberts, K., Green, B., Fares, M., Ambrosone, C. B., and Kadlubar, F. F. 2002. Carcinogen–DNA adducts in human breast epithelial cells. Environ. Mol. Mutagen. 39: 184–192.
   PubMed Web of Science ®Google Scholar
• Grover, P. L., Hewer, A., Pal, K., and Sims, P. 1976. The involvement of a diol-epoxide in the metabolic activation of benzo(a)pyrene in human bronchial mucosa and in mouse skin. Int. J. Cancer 18: 1–6.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer. 1983. Polycyclic aromatic compounds, Part 1, Chemical, environmental and experimental data. IARC Monogr. Eval. Carcinogen. Risk Chem. Hum. 32: 211–224. Lyon, France: IARC.
   Google Scholar
• International Agency for Research on Cancer. 2012. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. http://monographs.iarc.fr/ENG/Classification/index.php
   Google Scholar
• Jiang, Q., Lust, R. M., and DeWitt, J. C. 2013. Perfluorooctanoic acid induced-developmental cardiotoxicity: Are peroxisome proliferator activated receptor α (PPARα) and bone morphorgenic protein 2 (BMP2) pathways involved? J. Toxicol. Environ. Health A 76: 635–650.
   PubMed Web of Science ®Google Scholar
• Kang, S. C., and Lee, B. M. 2005. Effect of estrogen receptor (ER) on benzo[a]pyrene–DNA adduct formation in human breast cancer cells. J. Toxicol. Environ. Health A 68: 1833–1840.
   PubMed Web of Science ®Google Scholar
• Kim, H. S., and Lee, B. M. 1997. Inhibition of benzo[a]pyrene–DNA adduct formation by Aloe barbadensis Miller. Carcinogenesis 18: 771–776.
   PubMed Web of Science ®Google Scholar
• Kim, H. S., Byun, S. H., and Lee, B. M. 2005. Effects of chemical carcinogens and physicochemical factors on the UV spectrophotometric determination of DNA. J. Toxicol. Environ. Health A 68: 2081–2095.
   PubMed Web of Science ®Google Scholar
• Kulkarni, M. S., and Anderson, M. W. 1984. Persistence of benzo(a)pyrene metabolite: DNA adducts in lung and liver of mice. Cancer Res. 44: 97–101.
   PubMed Web of Science ®Google Scholar
• Kulkarni, M. S., Angerman-Stewart, J., and Anderson, M. W. 1984. Detection of in vivo DNA repair synthesis in mouse liver and lung induced by treatment with benzo(a)pyrene or 4-nitroquinoline 1-oxide. Cancer Res. 44: 1547–1550.
   PubMed Web of Science ®Google Scholar
• Kwack, S. J., and Lee, B. M. 2000. Correlation between DNA or protein adducts and benzo[a]pyrene diol epoxide I-triglyceride adduct detected in vitro and in vivo. Carcinogenesis 21: 629–632.
   PubMed Web of Science ®Google Scholar
• Lee, B. M., and Santella, R. M. 1988. Quantitation of protein adducts as a marker of genotoxic exposure: Immunologic detection of benzo[a]pyrene–globin adducts in mice. Carcinogenesis 9: 1773–1777.
   PubMed Web of Science ®Google Scholar
• Lee, B. M., Yoo, S. D., and Kim, S. 2002. A proposed methodology of cancer risk assessment modeling using biomarkers. J. Toxicol. Environ. Health A 65: 341–354.
   PubMed Web of Science ®Google Scholar
• Neumann, H. G. 1984. Analysis of hemoglobin as a dose monitor for alkylating and arylating agents. Arch. Toxicol. 56: 1–6.
   PubMed Web of Science ®Google Scholar
• Nie, J. H., Chen, Z. H., Liu, X., Wu, Y. W., Li, J. X., Cao, Y., Hei, T. K., and Tong, J. 2012. Oxidative damage in various tissues of rats exposed to radon. J. Toxicol. Environ. Health A 75: 694–699.
   PubMed Web of Science ®Google Scholar
• Owens, D. M., Wei, S., and Smart, R. C. 1999. A multihit, multistage model of chemical carcinogenesis. Carcinogenesis 20: 1837–1844.
   PubMed Web of Science ®Google Scholar
• Park, H. S., Park, Y. A., and Lee, B. M. 2002. Effects of pH and temperature on benzo[a]pyrene–DNA, –protein, and –lipid adducts in primary rat hepatocytes. J. Toxicol. Environ. Health A 65: 205–214.
   PubMed Web of Science ®Google Scholar
• Pedersen, M., Halldorsson, T. I., Autrup, H., Brouwer, A., Besselink, H., Loft, S., and Knudsen, L. E. 2012. Maternal diet and dioxin-like activity, bulky DNA adducts and micronuclei in mother-newborns. Mutat. Res. 734: 12–19.
   PubMed Web of Science ®Google Scholar
• Perera, F. P., and Weinstein, I. B. 1982. Molecular epidemiology and carcinogen–DNA adduct detection: New approaches to studies of human cancer causation. J. Chronic Dis. 35: 581–600.
   PubMedGoogle Scholar
• Perera, F. P., Santella, R. M., Brenner, D., Young, T. L., and Weinstein, I. B. 1988. Application of biological markers to the study of lung cancer causation and prevention. IARC Sci. Publ. 89: 451–459.
   PubMedGoogle Scholar
• Roh, T., Kwak, M. Y., Kwak, E. H., Kim, D. H., Han, E. Y., Bae, J. Y., Bang, du Y., Lim, D. S., Ahn, I. Y., Jang, D. E., Lim, S. K., Yoo, S. D., Kwack, S. J., Park, K. L., Lee, Y. J., Kim, K. B., Lee, J., Kim, H. S., and Lee, B. M. 2012. Chemopreventive mechanisms of methionine on inhibition of benzo(a)pyrene-DNA adducts formation in human hepatocellular carcinoma HepG2 cells. Toxicol. Lett. 208: 232–238.
   PubMed Web of Science ®Google Scholar
• Rossner, P., Jr., Svecova, V., Schmuczerova, J., Milcova, A., Tabashidze, N., Topinka, J., Pastorkova, A., and Sram, R. J. 2013. Analysis of biomarkers in a Czech population exposed to heavy air pollution. Part I: Bulky DNA adducts. Mutagenesis 28: 89–95.
   PubMed Web of Science ®Google Scholar
• Shugart, L. 1985. Quantitating exposure to chemical carcinogens: In vivo alkylation of hemoglobin by benzo[a]pyrene. Toxicology 34: 211–220.
   PubMed Web of Science ®Google Scholar
• Shugart, L., and Kao, J. 1985. Examination of adduct formation in vivo in the mouse between benzo(a)pyrene and DNA of skin and hemoglobin of red blood cells. Environ. Health Perspect. 62: 223–226.
   PubMed Web of Science ®Google Scholar
• Stowers, S. J., and Anderson, M. W. 1984. Ubiquitous binding of benzo[a]pyrene metabolites to DNA and protein in tissues of the mouse and rabbit. Chem. Biol. Interact. 51: 151–166.
   PubMed Web of Science ®Google Scholar
• Talaska, G., Jaeger, M., Reilman, R., Collins, T., and Warshawsky, D. 1996. Chronic, topical exposure to benzo[a]pyrene induces relatively high steady-state levels of DNA adducts in target tissues and alters kinetics of adduct loss. Proc. Natl. Acad. Sci. USA 93: 7789–7793.
   PubMed Web of Science ®Google Scholar
• Tang, D., Lee, J., Muirhead, L., Li, T. Y., Qu, L., Yu, J., and Perera, F. 2014. Molecular and neurodevelopmental benefits to children of closure of a coal burning power plant in China. PLoS One 9: e91966.
   PubMed Web of Science ®Google Scholar
• Vineis, P., and Perera, F. 2000. DNA adducts as markers of exposure to carcinogens and risk of cancer. Int. J. Cancer 88: 325–328.
   PubMed Web of Science ®Google Scholar
• Weyand, E. H., and Bevan, D. R. 1987. Covalent binding of benzo[a]pyrene to macromolecules in lung and liver of rats following intratracheal instillation. Cancer Lett. 36: 149–159.
   PubMed Web of Science ®Google Scholar